MEMPHIS, Tenn.--(BUSINESS WIRE)--Morgan Keegan & Company, Inc. has announced that Jan Wald, Ph.D., has joined the firm as a senior equity research analyst following the medical device industry. Wald, who is based in the firm’s Boston, Mass. office, joins Morgan Keegan from Noble Financial Group.
Wald was also formerly a managing director and medical technology analyst at the Stanford Group Company, A.G. Edwards and George K. Baum. At A.G. Edwards, he was also the Healthcare Group Leader. Before becoming a medical technology analyst, Wald held clinical trial management and engineering management positions at Guidant Corporation and engineering and engineering management positions at Honeywell Inc. Wald holds a Ph.D. from Brandeis University, an M.B.A. from the University of St. Thomas and a B.A. from Northeastern University. He was also a Post-Doctoral Fellow at the University of Minnesota’s Center for Research in Human Learning.
"The healthcare industry represents one-sixth of the U.S. economy and Morgan Keegan continues to expand our services throughout that sector,” said Elkan Scheidt, director of Equity Research for Morgan Keegan. “We are thrilled to have someone of Jan’s experience and industry knowledge joining our research efforts in the medical device sector."
“We remain focused on value-added service for our clients,” said Lawrence Keusch, head of Healthcare Research for Morgan Keegan. “The addition of Jan to the Morgan Keegan Healthcare team will broaden our footprint and reflects the firm’s commitment to this important sector. Given the firm’s presence in Tennessee and Boston, two major medical technology hubs, I believe Morgan Keegan is building a meaningful presence in the healthcare market.”
Morgan Keegan provides extensive research coverage and investment banking services throughout the healthcare industry, including healthcare information technology, healthcare services, medical devices, and healthcare REITs.
About Morgan Keegan & Company Inc.
Morgan Keegan & Company Inc., one of the nation’s largest regional full-service brokerage and investment banking firms, is the securities brokerage arm of Regions Financial Corporation (NYSE: RF). Headquartered in Memphis, Tenn., Morgan Keegan serves individual and institutional investors in over 300 offices in 20 states. Additional information about Morgan Keegan and Regions — a member of the S&P 100 Index — can be found at www.morgankeegan.com and www.regions.com.